Overview
NAV Performance
₹39.33
as on 16 Jul 2026Summary
An open ended equity scheme investing in Pharma and Healthcare Services Sector.
The investment objective of the scheme is to seek long term capital appreciation by investing atleast 80% of it’s net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.
However, there is no assurance or guarantee that the investment objective of the Scheme will be achieved. The Scheme does not assure or guarantee any returns.
Investment Philosophy
- The investment objective of the scheme is to seek long term capital appreciation by investing atleast 80% of it’s net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.
- Fund Manager will follow the AMFI sector classification for deciding the investment universe for the scheme.
- The scheme may also invest some portion of the investible funds in equity / equity related instruments of other companies.
- The Scheme may also invest some portion of the investible funds in debt and money market instruments.
Portfolio Positioning and Construction
The fund manager builds the portfolio around the following parameters:
- Endeavors to invest according to Growth at Reasonable Price.
- Prefers companies that have a long term potential for growth.
- The fund is generally dominated by large caps, with significant allocation to mid and small caps
- Rigorous fundamental research which includes parameters like management competitiveness, business competitiveness, corporate governance, growth prospects, past track record etc.
Exit Load
0.25% of NAV if redeemed/switched out before 30 days from the date of allotment.
Minimum Investment Amount
₹ 100
Lumpsum
₹ 5,000
Calculators
₹100
₹ 10 Lakhs
Worth of investments in last
This Fund
N.A.
0%
BSE HC TRI
N.A.
0%
Nifty 50 TRI
N.A.
0%
Holding Analysis
Key Measures ^
| Key Measures** | Fund | Benchmark |
|---|---|---|
| Standard Deviation | 16.74 | 16.34 |
| Sharpe Ratio | 0.9 | 1.11 |
| Portfolio Beta | 0.91 | NA |
| R Squared | 0.83 | NA |
| Treynor | 1.39 | NA |
| Jenson | -0.12 | NA |
Holdingsas on 30 Jun 2026
Sectorsas on 30 Jun 2026
Returns over the years
| Current value of ₹10,000 invested | ||||||
|---|---|---|---|---|---|---|
| Annualized (%) | BSE HC TRIBenchmark(%) | Nifty 50 TRIAdditional Benchmark(%) | Scheme | BSE HC TRIBenchmark(%) | Nifty 50 TRIAdditional Benchmark(%) | |
Since Inception 28 Dec 2015 | 13.58% | 11.38% | 12.43% | ₹38,124 | ₹31,044 | ₹34,270 |
| Last 1 Year | 8.63% | 12.00% | -5.42% | ₹10,863 | ₹11,200 | ₹9,458 |
| Last 3 Years | 22.68% | 24.79% | 8.80% | ₹18,474 | ₹19,443 | ₹12,882 |
| Last 5 Years | 15.14% | 14.72% | 9.98% | ₹20,240 | ₹19,874 | ₹16,097 |
Fund Managers
Rajat Srivastav
Managing since 16 Sept 2024
Riskometer
This product is suitable for investors who are seeking* :
- Investment in equity/equity related instruments of the companies in the Pharma & Healthcare sector in India.
- Long Term Capital Appreciation.
** Investors should understand that their principal will be at Very High risk
Scheme Documents
What is Tata India Pharma and Healthcare Fund?
How does Tata India Pharma and Healthcare Fund select stocks?
Is Tata India Pharma and Healthcare Fund a sectoral fund?
What are the benefits of investing in the pharma and healthcare sector?
What is the NAV of Tata India Pharma and Healthcare fund?
When was Tata India Pharma and healthcare fund Direct Plan-Growth launched?
Who should consider investing in this fund?
How does this fund differ from a healthcare index fund?
What is the risk profile of Tata India Pharma and Healthcare Fund?
How to invest in Tata India Pharma and Healthcare Fund online?